Drugs / NaCl
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07189091 Comparator | Oct 2025 → Apr 2028 expected | — | University Hospital, Antwerp | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07189091 ↗ |
| Known as | normal saline | “NaCl 0.9% (normal saline) for fluid creep” NCT07189091 ↗ |
| Route | Intravenous | “All infusions to keep intravenous lines open are NaCl 0.9%.” NCT07189091 ↗ |